1Associate Professor, Department of Pharmacology, BRLSABVM GMC, Rajnandgaon, Chhattisgarh
2Professor, Department of Pharmacology, Dr. N Y Tasgaonkar Institute of Medical Sciences, Karjat, Maharashtra
*Corresponding Author E-mail: dr.tabishahmed@gmail.com
Online published on 4 May, 2024.
The National Pharmacovigilance Programme is coordinated by the Indian Pharmacopoeia Commission at Ghaziabad. The Pharmacovigilance Programme of India (PvPI) is now in full swing. We have a network of some 90 adverse drug reaction (ADR) Monitoring Centres (AMCs) across the country. The programme provides financial, logistic and technical support to the AMCs. Initially, only health professionals could report the ADR. Recently PvPI has included all people who consume medicine and not just health professionals, to report ADR. A toll free consumer helpline (1800 180 3024 operational on weekdays during office hours) and a dedicated email address (PvPI.compat@gmail.com) have been launched to encourage people to report ADRs.
To study awareness and attitude of medicine consumers towards ADR reporting.
This is a questionnaire based study where consumers will be given the questionnaire regarding ADRs and their reporting.
Time duration 3months.
It is important to spread awareness and importance about ADR reporting amongst the general population.
ADR, Pharmacovigilance, Consumers, Knowledge
